Chengdu Olymvax Biopharmaceuticals Inc Class A 688319
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 8.49
- Day Range
- CNY 8.40–8.68
- 52-Week Range
- CNY 7.06–25.00
- Bid/Ask
- CNY 8.55 / CNY 8.56
- Market Cap
- CNY 3.48 Bil
- Volume/Avg
- 2.5 Mil / 5.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 356.72
- Price/Sales
- 6.88
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 440
- Website
- http://www.olymvax.com
Comparables
Valuation
|
Metric
|
688319
|
688739
|
301207
|
|---|---|---|---|
Price/Earnings (Normalized) | 356.72 | 25.87 | 17.78 |
Price/Book Value | 3.85 | 1.21 | 2.04 |
Price/Sales | 6.88 | 6.63 | 5.63 |
Price/Cash Flow | 289.62 | 19.42 | 16.35 |
Price/Earnings
688319
688739
301207
Financial Strength
|
Metric
|
688319
|
688739
|
301207
|
|---|---|---|---|
Quick Ratio | 2.07 | 20.51 | — |
Current Ratio | 2.27 | 22.19 | — |
Interest Coverage | 4.42 | 331.34 | — |
Quick Ratio
688319
688739
301207
Profitability
|
Metric
|
688319
|
688739
|
301207
|
|---|---|---|---|
Return on Assets (Normalized) | −1.80% | 3.62% | 9.39% |
Return on Equity (Normalized) | −3.02% | 3.78% | 11.86% |
Return on Invested Capital (Normalized) | −2.06% | 3.16% | 11.24% |
Return on Assets
688319
688739
301207
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Bdmgwsynt | Bxsg | $593.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Zgvhnjjp | Hggtvd | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Thlfvfllb | Fmwmkhm | $106.7 Bil | |
MRNA
| Moderna Inc | Bvhdsppyx | Gwpj | $50.8 Bil | |
BNTX
| BioNTech SE ADR | Wkdxbvtq | Thdq | $22.4 Bil | |
ARGX
| argenx SE ADR | Txlgmmgjs | Jxgg | $22.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Jxdtssgzc | Xghkd | $19.1 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Zznvttd | Hhxns | $14.6 Bil | |
INCY
| Incyte Corp | Jvpbzfvr | Yxvzdv | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Jwgwfljq | Pmnmv | $12.6 Bil |